# 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

> **NCT00365950** · PHASE4 · COMPLETED · sponsor: **British Thoracic Society** · enrollment: 2400 (—)

## Conditions studied

- Deep Vein Thrombosis
- Pulmonary Embolism
- Deep Vein Thrombosis With Pulmonary Embolism

## Interventions

- **DRUG:** Duration of anticoagulation
- **DRUG:** Warfarin duration

## Key facts

- **NCT ID:** NCT00365950
- **Lead sponsor:** British Thoracic Society
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 2400 (—)
- **Last updated:** 2006-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365950, "3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00365950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*